VIVIMEDLAB

Healthcare Drug Manufacturers - Specialty & Generic

★ Watchlist ⧉ Add to bucket

₹6.67

+1.99% today · 30d +33.67%

as of 2026-09-04

Price · Daily Candles

Detect candlestick pattern

AI narrative is temporarily unavailable for VIVIMEDLAB. The deterministic sections below render from live data.

₹ Latest Earnings · Q ending 2025-12-31

REVENUE

₹16 Cr

-56.21% YoY

NET PROFIT

₹-17 Cr

OPM

-68.31%

-71.38pp YoY

EPS

₹-0.88

Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-11.2% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.

◇ Sector Position

PEERPEROCE %

VIVIMEDLAB—-8.0

SUNPHARMA37.5721.44

DIVISLAB89.1821.56

ZYDUSLIFE24.6424.22

+ 2 more peers — sign in to view

ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

SCORE / 100

Overall

6-axis composite of the sections below.

Performance UNDERPERFORMER 5

Valuation — —

Growth MUTED 30

Profitability LOW 5

Technicals NEUTRAL 65

Risk LOW 90

Key Stats

P/B

-1.12

52W HIGH

₹29.4

OFF HIGH

-77.31%

MKT CAP

₹56 Cr

◉ Active Signals

MACDBullish0.0457

RSI(14)Bullish64.86

⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold VIVIMEDLAB and at what entry.